<DOC>
	<DOCNO>NCT01287832</DOCNO>
	<brief_summary>There increased failure rate treatment Staphylococcus Aureus Bacteremia ( SAB ) traditional dos vancomycin , standard care patient MRSA bacteremia last 40 year . This largely attributed isolates increase resistance vancomycin ( increased MIC ) . Daptomycin antibiotic approve several year ago treatment SAB increasingly use MRSA bacteremia due isolates increase MIC . Increased dos recommend drug treatment infection without trial demonstrate relative efficacy safety high dos . This study randomize patient SAB due MRSA increase MIC determine relative efficacy safety vancomycin daptomycin use high traditional dos .</brief_summary>
	<brief_title>Vancomycin Versus Daptomycin Treatment Methicillin-resistant Staphylococcus Aureus Bacteremia Due Isolates With High Vancomycin Minimum Inhibitory Concentrations ( MICs )</brief_title>
	<detailed_description />
	<mesh_term>Bacteremia</mesh_term>
	<mesh_term>Daptomycin</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Methicillin</mesh_term>
	<criteria>18 year age older Signed inform consent All case suspect MRSA bacteremia determine patient least one blood culture grow grampositive cocci cluster clinical syndrome consistent true bacteremia include fever , hypothermia ( temperature &lt; 36.0ยบ C ) , tachycardia ( heart rate &gt; 100 beats/minute ) , hypotension ( systolic blood pressure &lt; 90 mm Hg ) clinical feature sepsis . All case rightsided native valve endocarditis due MRSA Patients diagnose leftsided native valve endocarditis randomization continue study Patients MRSA bacteremia associate infected foreign body , include vascular prosthesis , orthopedic prosthesis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Methicillin-resistant</keyword>
	<keyword>Staphylococcus aureus</keyword>
</DOC>